Vitamin D Pilot Study in Patients With Multiple Sclerosis
Phase 1
Completed
- Conditions
- Relapsing Remitting Multiple Sclerosis
- Interventions
- Drug: 19 nor vitamin d
- Registration Number
- NCT01257958
- Lead Sponsor
- University of Wisconsin, Madison
- Brief Summary
Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- relapsing remitting MS
Exclusion Criteria
- MRI contraindicated
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 19 nor vitamin d 19 nor vitamin d -
- Primary Outcome Measures
Name Time Method MRI Measure of new active lesions, observation vs. treatment
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UW-Madison
🇺🇸Madison, Wisconsin, United States
UW-Madison🇺🇸Madison, Wisconsin, United States